logo-loader
viewGogo Inc

Gogo shares climb after flying past 2Q profit and revenue estimates

Gogo's 2Ku inflight systems are in place on 785 aircraft run by 12 airlines

rows of seats on an airplane
Gogo has recently launched its inflight systems on Iberia Airlines as well as Alaska Airlines

Shares of in-flight internet provider Gogo (Nasdaq:GOGO) climbed Wednesday morning after flying past Wall Street’s profit and revenue estimates for the second quarter.

The Chicago-based company reported a loss of US$0.47 per share on revenue of US$227.46mln. This was a far better showing than Wall Street’s consensus projection of a loss of US$0.75 on revenue of US$207.64mln.

Optimistic about the company's growth projections, investors pushed up Gogo's shares about 7% right after the open to US$4.10, after adding as much as 14% in the premarket.

A company on the move

The company said its Gogo 2Ku inflight systems are now in place on 785 aircraft run by 12 global airlines and that it added 139 Ku systems to aircraft in the quarter.

Gogo’s revenue from its business aviation group rose 28% from the year-ago period to US$74.2mln while its revenue from its North American commercial aviation company jumped 19% to US$119.7mln.

“Our business aviation segment achieved its highest-ever quarterly revenue and EBITDA and we believe this segment is well-positioned for continued growth,” said CEO Oakleigh Thorne in a statement.

Looking at its international growth, Gogo’s revenue from its commercial aviation group for the rest of the world increased to US$33.6mln, up from US$14.1mln in the year-ago quarter.

Gogo recently launched its service on Air Canada’s international aircraft fleets as well as Iberia Airlines and Alaska Airlines.

Gogo expects full-year revenue to fall in the range of US$865mln to US$935mln.

Based in Chicago, Gogo provides broadband connectivity and related services for aircraft.

Contact Ellen Kelleher at [email protected]

Quick facts: Gogo Inc

Price: 2.16 USD

NASDAQ:GOGO
Market: NASDAQ
Market Cap: $180.94 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Heat Biologics forms partnership with Waisman Biomanufacturing to...

Heat Biologics, Inc. (NASDAQ:HTBX) CEO Jeff Wolf tells Proactive the clinical-stage biopharmaceutical company is collaborating with Waisman Biomanufacturing to establish a partnership to manufacture Heat's coronavirus vaccine for expected Phase 1 clinical trials. Wolf says North...

2 minutes ago

2 min read